Some head and neck cancer patients benefit from continued checkpoint inhibitor treatment - EurekAlert (press release)

EurekAlert (press release)

Some head and neck cancer patients benefit from continued checkpoint inhibitor treatment EurekAlert (press release) WASHINGTON -- New research suggests that some patients with head and neck cancers can benefit by continuing treatment with an immunotherapy drug after their tumors show signs of enlargement according to investigators at Dana-Farber Cancer Institute ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nCINxm
via IFTTT